Volume 22 - Issue 3 - March 2014
03/05/2014
Kamran I. Muhammad, MD, FACC, FSCAI
Oklahoma Heart Institute is part of the Hillcrest Healthcare system, located in Tulsa, Oklahoma. We are a full-service cardiology practice and heart hospital, and began performing TAVR in May 2012 with great success.
Oklahoma Heart Institute is part of the Hillcrest Healthcare system, located in Tulsa, Oklahoma. We are a full-service cardiology practice and heart hospital, and began performing TAVR in May 2012 with great success.
Oklahoma Heart Institute is part...
03/05/2014
Cath Lab Digest
03/05/2014
Carolyn Winn, RN, BSN; Arlene Porter, MSN, RN-C; Dennis Kim, MD, PhD, FACC, FSCAI
Our facility is comprised of three labs: one dedicated electrophysiology (EP) lab and two diagnostic/interventional labs. Construction of our new hybrid lab began in the first quarter of 2014.
Our facility is comprised of three labs: one dedicated electrophysiology (EP) lab and two diagnostic/interventional labs. Construction of our new hybrid lab began in the first quarter of 2014.
Our facility is comprised of...
03/05/2014
Cath Lab Digest
Cath Lab Management
03/05/2014
Sheree Schroeder, RN, BSN, RDCS, FASE
Quality cardiovascular patient care should ensure that the right patient has the right procedure with the right execution resulting in the right outcome, as benchmarked by the NCDR.
Quality cardiovascular patient care should ensure that the right patient has the right procedure with the right execution resulting in the right outcome, as benchmarked by the NCDR.
Quality cardiovascular patient...
03/05/2014
Cath Lab Digest
03/05/2014
Marwan F. Jumean, MD; Navin Kumar Kapur, MD
When bedside examination, laboratory testing, echocardiography or other imaging studies fail to identify a cause for LVAD dysfunction, an invasive hemodynamic assessment may be necessary.
When bedside examination, laboratory testing, echocardiography or other imaging studies fail to identify a cause for LVAD dysfunction, an invasive hemodynamic assessment may be necessary.
When bedside examination,...
03/05/2014
Cath Lab Digest
Stem Cells in the Cath Lab
03/05/2014
Howard T. Walpole, Jr., MD, MBA
Data from animal studies and clinical trials in humans suggests that the introduction of stem cells and/or specific genes into the heart can improve outcomes. However, results have been mixed.
Data from animal studies and clinical trials in humans suggests that the introduction of stem cells and/or specific genes into the heart can improve outcomes. However, results have been mixed.
Data from animal studies and...
03/05/2014
Cath Lab Digest
03/05/2014
Kintur Sanghvi, MD, FACC, FSCAI
The science of RDN had made noteworthy progress and yet with Medtronic’s announcement that its SYMPLICITY-3 (S-3) trial did not meet the predefined effectiveness endpoint dampened enthusiasm and, rightfully so, put a pause on the sprint of...
The science of RDN had made noteworthy progress and yet with Medtronic’s announcement that its SYMPLICITY-3 (S-3) trial did not meet the predefined effectiveness endpoint dampened enthusiasm and, rightfully so, put a pause on the sprint of...
The science of RDN had made...
03/05/2014
Cath Lab Digest
03/05/2014
Adele Serio, MSN, RN, RCIS
The Vascular Center of Colorado (VCC) recently engaged in a successful agreement to purchase coronary drug eluting stents (DES) with a market share commitment to a single vendor.
The Vascular Center of Colorado (VCC) recently engaged in a successful agreement to purchase coronary drug eluting stents (DES) with a market share commitment to a single vendor.
The Vascular Center of Colorado...
03/05/2014
Cath Lab Digest
03/05/2014
Ray D. Smith, MD
We like to utilize the Axera Access Device because it can be used to gain access across multiple procedures in the same patient.
We like to utilize the Axera Access Device because it can be used to gain access across multiple procedures in the same patient.
We like to utilize the Axera...
03/05/2014
Cath Lab Digest
03/05/2014
Louis Salvaggio, MD; Raghotham R. Patlola, MD, FACC
In light of recent technological developments and surprising pivotal clinical trial results, the future of renal denervation took a surprisingly tenuous turn in early 2014.
In light of recent technological developments and surprising pivotal clinical trial results, the future of renal denervation took a surprisingly tenuous turn in early 2014.
In light of recent technological...
03/05/2014
Cath Lab Digest
03/05/2014
Zaheed Tai, MD, DO, FACC, FSCAI; Orlando Marrero, RCIS, MBA
This is a 79-year-old gentleman with a history of coronary artery disease, status post bypass x 3 (left internal mammary artery to the left anterior descending coronary artery [LIMA->LAD]; saphenous vein graft to the right posterior...
This is a 79-year-old gentleman with a history of coronary artery disease, status post bypass x 3 (left internal mammary artery to the left anterior descending coronary artery [LIMA->LAD]; saphenous vein graft to the right posterior...
This is a 79-year-old gentleman...
03/05/2014
Cath Lab Digest
